You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Hungary

Jul 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Moderate growth with decreasing constant sales

Consumer health still faces decreasing sales in constant terms in 2011 due to the deepening economic crisis in Hungary. Nevertheless, most Hungarians are not significantly reducing their spending on consumer health products, as strengthening health-consciousness and active advertising activity by manufacturers hold consumers’ interest, despite the difficult economic circumstances. Manufacturers are not able to avoid price increases, which also helps to maintain current market growth.

Manufacturers invest heavily in advertising

The importance of influencing consumers through advertising significantly increases during the crisis within consumer health market. While other industries that were more seriously influenced by the economic crisis, such as the auto industry, remarkably reduced their spending on advertising, consumer health takes the lead from the food industry regarding advertising spend. Manufacturers not only increase their spending, but also restructure it; focusing on television, outdoor and magazine advertisements. Leading advertisers remain the biggest multinationals, namely Bayer, Sanofi-Aventis, Novartis and Reckitt Benckiser.

Multinationals dominate consumer health

Multinationals are able to maintain their leading positions in consumer health in 2011. Sanofi-Aventis Zrt, Novartis Hungária Kft and Bayer Hungária Kft invest in both product development and advertising in order to maintain consumers’ interest. Béres Gyógyszergyár Zrt ranks third, proving that consumers’ trust in a traditional Hungarian brand is still a very important factor in consumer choice. Béres Gyógyszergyár retains the lead in dietary supplements, mainly due to the unbroken success of Béres drops.

Chemists/pharmacies preserves its leading role in distribution

Chemists/pharmacies remains the most important distribution channel in consumer health in 2011. 2011 confirms that the market liberalisation of 2007 did not have a significantly negative effect on pharmacies’ market position in Hungary, especially in the OTC category. Although drugstores invested in selling OTC products, realising the weak consumer demand for such products, they now rather focus on supplying vitamins and dietary supplements to consumers. Direct selling is the most important non-store channel in 2011, maintaining its strong position in vitamins and dietary supplements and weight management.

Steady growth is predicted over forecast period

Consumer health is predicted to perform slightly better over the forecast period, than during the economic crisis seen over the review period. Although both European and Hungarian economic forecasts are pessimistic for the year 2012, general economic conditions are likely to improve in the longer term. As consumer health was one of the markets less negatively affected by the crisis, current market growth is not expected to turn negative, but predicted to keep on increasing due to manufacturers’ massive advertising activities.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Hungary with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Hungary, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Hungary for free:

The Consumer Health in Hungary market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Hungary?
  • What are the major brands in Hungary?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Hungary - Industry Overview

EXECUTIVE SUMMARY

Moderate growth with decreasing constant sales

Manufacturers invest heavily in advertising

Multinationals dominate consumer health

Chemists/pharmacies preserves its leading role in distribution

Steady growth is predicted over forecast period

KEY TRENDS AND DEVELOPMENTS

Lengthening economic crisis, deepening debt crisis

Pharmacies in difficult situation

Moderate product development, massive advertising

Central European regulation of health claims determines innovation trends in vitamins and dietary supplements

New age arrived for smokers

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Penetration of Private Label by Category 2006-2011
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC Switches 2009-2011

SOURCES

  • Summary 2 Research Sources

Consumer Health in Hungary - Company Profiles

Béres Gyógyszergyár Zrt in Consumer Health (Hungary)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Béres Gyógyszergyár Zrt: Competitive Position 2011

Bioextra Zrt in Consumer Health (Hungary)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Bioextra Zrt: Competitive Position 2011

Egis Gyógyszergyár Nyrt in Consumer Health (Hungary)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 11 Egis Gyógyszergyár Nyrt: Competitive Position 2011

Meditop Gyógyszeripari Kft in Consumer Health (Hungary)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 14 Meditop Gyógyszeripari Kft: Competitive Position 2011

Naturland Magyarország Kft in Consumer Health (Hungary)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 17 Naturland Kft: Competitive Position 2011

Adult Mouth Care in Hungary - Category Analysis

HEADLINES

TRENDS

  • In 2011, adult mouth care was still suffering the negative effects of the economic downturn, however, constant sales decline slowed down and sales increased in current terms. Although Hungarians’ oral hygiene still lags behind Western European customs, last years’ campaigns have begun to slowly change people’s attitude and more and more consumers pay attention to their oral health. Nevertheless, using oral hygiene products is still not a general part of oral care and these products are treated as non-essential goods in everyday life.

SWITCHES

COMPETITIVE LANDSCAPE

  • CSC Pharmaceuticals Handels led sales in 2011 with a 40% value share thanks to the unbroken success of Tantum Verde. Tantum Verde is widely used to disinfect teeth and the palate and it is also popular among people who suffer from sore throats. Extractum-Pharma Zrt held second position with a 25% value share, as its Mundisal gel was the second best-selling brand in adult mouth care. GlaxoSmithKline Kft was third in ranking with a 20% value share due to its Chlorhexamed and Corsodyl brands.

PROSPECTS

  • Adult mouth care is expected to benefit from the strengthening health-consciousness of Hungarians and sales are predicted to increase at a constant value CAGR of 1% over the forecast period. Nevertheless, growth is not anticipated to be dynamic, but slight as consumer habits are slowly changing in oral care and manufacturers spend limited amounts on advertising.

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2006-2011
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 14 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 15 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Hungary - Category Analysis

HEADLINES

TRENDS

  • Market growth of analgesics in 2011 was significantly affected by switch decision made in September 2010. Topical analgesics with the active ingredient of ketoprofen were switched from OTC to Rx. Although the switch concerned only four products, value sales of topical analgesics/anaesthetic decreased by nearly 13% in 2011. Among re-switched products was Fastum gel, which had been the best-selling brand in the category holding a 20% value share in 2009. According to pharmacists, many people are loyal to tried brands and they prefer to visit the doctor for a prescription than try a new brand.

SWITCHES

COMPETITIVE LANDSCAPE

  • Sanofi Aventis Zrt maintained its leading position in analgesics, accounting for more than 31% of value sales in 2011. Sanofi Aventis’ Algoflex brand was the best selling product in analgesics, holding a value share of 24% due to the gradual growth of its sales since 2007 when the most popular Rx analgesics brands were switched to Rx. Bayer Hungária Kft was second in ranking with the Aspirin brand, holding a 12% value share. Bayer’s Asprin has many variants from tablets to powder in different strengths and they are traditionally popular in Hungary. Pfizer Kft’s value share stagnated at 11% in 2011 due to the success of the third best-selling systemic analgesics brand, Advil.

PROSPECTS

  • Sales of analgesics are expected to increase at a CAGR of 1% in constant value terms over the forecast period. Constant growth is expected to turn to positive as no significant switches are expected and the strengthening self-medication trend will affect sales growth positively. Manufacturers will likely invest in product development, especially in ibuprofen. As worries about the harmful side-effects of acetaminophen are expected to strengthen over the forecast period, manufacturers are expected to invest in other categories instead.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2006-2011
  • Table 19 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 21 Analgesics Company Shares by Value 2007-2011
  • Table 22 Analgesics Brand Shares by Value 2008-2011
  • Table 23 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Hungary - Category Analysis

HEADLINES

TRENDS

  • Hectic lifestyles, cumulating personal problems caused by the economic downturn and rising pressure on people, affected both value and volume sales of calming and sleeping products positively in 2011. Many Hungarians prefer trying non-prescription calming and sleeping product before visiting the doctor for Rx medicines, since they are afraid of getting used to chemicals and suffering from side-effects. Moreover, doctors also suggest non-prescription products as a first step in treatment as these herbal remedies can solve minor health problems. Therefore, current value sales of calming and sleeping products recorded 6% growth in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • Teva Magyarország Zrt maintained its leading position in calming and sleeping products, holding a 37% value share. Teva Magyarország produces Valeriana, the best-selling brand in the category, which is available in tablet and soft gel capsule format as well. Gebro Broschek was the second in ranking, accounting for 30% of value sales thanks to its Hova brand which has been a well-known brand in Hungary for more than a decade. Naturprodukt held third position with a value share of nearly 6%, due to the popularity of Cirkulin Valeriana.

PROSPECTS

  • Calming and sleeping is predicted to see stable retail value sales growth over the forecast period. Accelerated lifestyles are expected to cause insomnia and burden people’s nervous systems. As many consumers are averse to taking chemicals, they will rather try non-prescription herbal remedies to solve their problems. Well-established brands are expected to perform well and attract consumers. Thus, constant retail value sales are expected to increase with a total of 6%.

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2006-2011
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 27 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 28 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Hungary - Category Analysis

HEADLINES

TRENDS

  • In 2011, value sales of cough, cold and allergy remedies increased only in current terms, while constant sales of the category slightly decreased. As the flu season was moderate, no significant boosting effect influenced sales. Similarly to the previous years, consumers preferred combination products to any other kinds of treatments heavily affected by massive advertising activity by manufacturers.

SWITCHES

COMPETITIVE LANDSCAPE

  • Novartis Hungária Healthcare Kft led sales in 2011 holding a 22% value share in cough, cold and allergy remedies. The company manufactures Neo Citran, which is the best-selling brand in combination products, and also in the whole cough, cold and allergy remedies category. Other popular brands, e.g. Vibrocil, Otrivin and Mebucain, are also well-established brands that contributed to Novartis’ success. Gyori Keksz Kft maintained the second position with market-leading medicated confectionery brand, Negro. Although Gyori Keksz Kft is present mainly in packaged food, with the Negro brand it held a 10% value share in cough, cold and allergy remedies. Pfizer Kft ranked third thanks to its strong positions in medicated confectionery and cough remedies. Pfizer accounted for 9% of value sales with Halls, Robitussin and Vita-C.

PROSPECTS

  • Value sales of cough, cold and allergy remedies are expected to stagnate in constant terms over the forecast period as market growth will likely remain marginal from year to year. Although some categories such as antihistamines/allergy remedies are expected to perform well due to the increasing number of people who suffer from allergy symptoms, other categories e.g. nasal decongestant drops or oral decongestants will continue to decline. Manufacturers will be able to retain consumers’ interest only with continuous development, however, cough, cold and allergy remedies has already reached maturity and companies are not very active in terms of innovation.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 33 Sales of Decongestants by Category: Value 2006-2011
  • Table 34 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 36 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Hungary - Category Analysis

HEADLINES

TRENDS

  • Value sales of digestive remedies continued to increase steadily in 2011, recording 3% current value growth, while constant sales slightly declined. Consumer demand was driven by two contrary effects: Healthy eating habits are coming to the fore, thus fewer people suffer from digestive problems, while accelerated and stressful lifestyles exacerbate digestive problems. Constant growth remained negative in most categories, only proton pump inhibitors saw significant growth, due to the newness of the category.

SWITCHES

COMPETITIVE LANDSCAPE

  • Berlin-Chemie Budapest led digestive remedies, accounting for 14% of value sales. Berlin-Chemie’s Espumisan brand has been the leader in digestive remedies for years, and the company has invested a lot in its promotion through the years. The company is also present in digestive enzymes with Mezym Forte and Pangrol. Sanofi-Aventis held second position with a 9% value share, due to a number of popular brands. Sanofi’s best-selling brand was No-Spa, which has been a traditional well-known brand for decades in Hungary. Solvay Pharma Kft ranked third with Kreon and Pankreoflat brands accounting for 8% of value sales.

PROSPECTS

  • Value sales of digestive remedies are expected to stagnate over the forecast period. With the spread of healthy eating habits, people will likely face fewer digestive problems, however, accelerated lifestyles, and overall stress will counter this and strengthen digestive problems. These two contrary effects will result in stagnating sales. Poor innovation that characterised the category in previous years, will likely last over the forecast period too. Therefore, manufacturers will have to invest in advertising to avoid decreasing value sales.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 43 Digestive Remedies Company Shares by Value 2007-2011
  • Table 44 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Hungary - Category Analysis

HEADLINES

TRENDS

  • Current value sales of ear care stagnated in 2011 and sales continued to decrease in constant terms. Ear care remained a quite underdeveloped category of consumer health as the year 2011 was uneventful. Most ear care products are Rx in Hungary and people prefer visiting the doctor with ear problems rather than treating it themselves.

SWITCHES

COMPETITIVE LANDSCAPE

  • Teva Magyarország was ranked first in ear care, accounting for 86% of total value sales. Teva produces Otipax, the only non-prescription ear care product to treat ear pain. Laboratoires Diepharmex was the second in ranking holding an 11% value share with Audispray. Audispray is suggested for ear cleaning and available in three formats in pharmacies. Although Audispray is frequently advertised in the media, consumers are not really open to it and doctors do not suggest it to patients either, as they negatively affect the level of protection in ears.

PROSPECTS

  • Value sales of ear care are expected to decrease by a total of 13% between 2011 and 2016, in constant terms. Ear care will likely remain a small and underdeveloped category within consumer health, as Hungarians will continue to turn to doctors with ear problems instead of self-medicating. The use of ear-cleaning sprays is not expected to spread dynamically as doctors are against it. Thus, there will be no significant products that can generate increasing sales in the category.

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2006-2011
  • Table 48 Sales of Ear Care: % Value Growth 2006-2011
  • Table 49 Ear Care Company Shares by Value 2007-2011
  • Table 50 Ear Care Brand Shares by Value 2008-2011
  • Table 51 Forecast Sales of Ear Care: Value 2011-2016
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2011-2016

Eye Care in Hungary - Category Analysis

HEADLINES

TRENDS

  • Air pollution causes allergy symptoms for more and more people, who need allergy eye care products to treat these problems. With the spread of computer use, an increasing number of people suffer from the unpleasant symptoms of red eye and dry eye. Dry eye is a common health problem for the older generation as well, thus the aging population also generated increasing demand for eye care products. Therefore, eye care sales increased by 5% in current terms in 2012.

SWITCHES

COMPETITIVE LANDSCAPE

  • Pfizer Kft was category leader in eye care in 2011, accounting for 41% of current value sales. Pfizer’s Visine has been the best-selling brand for years in the category and it is available in variants namely for tired, dry and sensitive eyes. Alcon Hungária Kft was second in ranking with a value share of 27%, primarily due to Tears Naturale that was the second-best selling brand in standard eye care. Alcon Hungária markets other popular brands, such as Dacrolux and Lubrifilm. Teva Magyarország Zrt held an 11% value share in eye care, with such traditional brands as Humalac and Opticrom.

PROSPECTS

  • Eye care sales are expected to increase faster from 2011 to 2016 than over the review period. Factors that generate sales will ensure stable growth as computer use and allergy is likely to affect more and more Hungarians and the presence of the older generation will continue to strengthen in society. Thus, value sales are expected to increase at a CAGR of 2% in constant terms over the forecast period.

CATEGORY DATA

  • Table 53 Sales of Eye Care by Category: Value 2006-2011
  • Table 54 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 55 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 56 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 57 Eye Care Company Shares by Value 2007-2011
  • Table 58 Eye Care Brand Shares by Value 2008-2011
  • Table 59 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 60 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Hungary - Category Analysis

HEADLINES

TRENDS

  • Use of herbal/traditional products is widespread and common in Hungary and this popularity continued to strengthen in 2011 as health-promotion came to the fore. Many Hungarians worry about the possible negative side-effects of chemicals, therefore they turn to herbal/traditional products which are considered to be safer and gentler. Herbal/traditional products are easily available in Hungary nowadays, and retail outlets tend to allocate more shelf space to herbal products to attract consumers.

COMPETITIVE LANDSCAPE

  • Gyori Keksz Kft led sales in 2011 with stable 11% share of herbal/traditional products. Gyori Keksz Kft produces Negro, the most popular medicated confectionery, which is available in many variants containing menthol, eucalyptus, honey and lemon. Berlin-Chemie Budapest held the second position accounting for 8% of value sales due to its popular dietary supplement, Prostamol Uno. Prostamol Uno contains extract of serenoa to treat men’s health. Teva Magyarország Zrt was third in the ranking with an 8% retail value sales share due to the popularity of more brands, namely Bilobil, Saballo, Valerian and Peponen.

PROSPECTS

  • Herbal/traditional products will continue to benefit from the steadily growing popularity of herbal remedies, especially herbal/traditional dietary supplements. Therefore value sales are likely to increase at a constant CAGR of 1% from 2011 to 2016. Market growth will be driven by the strengthening health-promotion trend and manufacturers’ activities both in terms of innovation and advertising.

CATEGORY DATA

  • Table 61 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 62 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 63 Herbal/Traditional Products Company Shares 2007-2011
  • Table 64 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 65 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 66 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Hungary - Category Analysis

HEADLINES

TRENDS

  • 2011 was quite eventless in medicated skin care. Manufacturers did not launch new products in the category, they were not especially innovative regarding advertising, and thus constant sales growth remained marginal. Medicated skin care has been facing strengthening competition from the cosmetics industry for years, which significantly threatens sales of some categories, such as acne treatments. Cosmeceuticals recognised the need for medicated skin care products and launched whole product families which are as attractive in packaging and design as cosmetic products, however they have proven medicated effects.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bayer Hungária Kft led medicated skin care in 2011, holding a value share of 20%. Bayer’s Canesten and Canespro are best-selling products in topical antifungals due to the well-established brand name and frequent advertising. Janssen-Cilag Hungary Kft was second in ranking accounting for 11% of value sales thanks to Pevaryl, the best-selling vaginal antifungal and Nizoral, the leader within medicated shampoos. Novartis Hungária Healthcare Kft maintained its third position with a 9% value share, as its Fenistil and Lamisil brands remained popular among Hungarians in 2011.

PROSPECTS

  • Medicated skin care is expected to stagnate in constant terms from 2011 to 2016. Manufacturers are predicted to maintain sales due to a couple of new products and promotions; nevertheless, no significant increase is expected over the forecast period. Some categories, especially antipruritics, will face strengthening competition from the cosmetics industry, as more and more cosmeceuticals offer products for sensitive and problematic skin. Lengthening negative effects of the economic crisis will also limit market growth.

CATEGORY DATA

  • Table 67 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 68 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 69 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 70 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 71 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 72 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 73 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Hungary - Category Analysis

HEADLINES

TRENDS

  • NRT smoking cessation aids have been facing steadily decreasing demand for years, and this trend did not change in 2011 either. As the government still had not made the necessary strict tobacco bans in 2011, Hungarian smokers were not forced into giving up smoking. Although the number of male smokers decreased slightly in 2011, more and more women smoke, and children try smoking earlier than ever. In November 2011, the government significantly increased tax on cigarettes, however it was still not big enough to deter smokers. Therefore, value sales of NRT smoking cessations aids continued to decrease in 2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline Kft led sales in 2011 accounting for 64% of value sales. GlaxoSmithKline produces the Niquitin brand, which was the leader both in NRT patches and NRT lozenges. Pfizer held the second position with a 19% value share due to Nicorette, which is available in gum and patch variant. Novartis Hungária Healthcare was third in ranking, accounting for 11% of value sales. Novartis’s Nicotinell was present in all three formats: Gum, lozenge and patches, and was the best-selling brand in gum.

PROSPECTS

  • Value sales of NRT smoking cessation aids are expected to continue to decrease at a constant CAGR of -4 % over the forecast period. Due to the smoke bans introduced from January 2012 and the further increasing cigarette prices more and more people are likely to decide on cessation. Nevertheless since NRT smoking cessation aids are quite expensive for most people in current economic situation, sales will likely decrease from 2011 to 2016 as Hungarians will opt for cheaper cessation alternatives.

CATEGORY DATA

CATEGORY INDICATORS

  • Table 74 Number of Smokers by Gender 2006-2011
  • Table 75 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 76 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 77 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 78 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 79 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 80 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 81 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Hungary - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition sales dynamically increased in recent years, as bodybuilding became fashionable and supply of different products widened. In 2011 the dynamic growth slowed down due to the negative effects of the economic downturn, as many people turned to cheaper product variants to save money. However, constant market value growth remained positive and manufacturers’ innovative activity helped to maintain consumers’ overall interest in sports nutrition.

COMPETITIVE LANDSCAPE

  • Scitec Kft led sales in 2011, holding a 43% value share in sports nutrition. Scitec Kft offers a wide range of products for bodybuilders, organises and promotes numerous sports events and invests a lost in communication with consumers. JLM Powerline Kft was second in ranking with the Biotech brand, accounting for 24% of value sales. Biotech products are sold through the wide network of franchise outlets, which are located in busy shopping centres. Weider Nutrition International was the third biggest market player in sports nutrition with an 8% value share, as the Weider brand has been available for the longest time in Hungary and many loyal consumers still insist on it.

PROSPECTS

  • Sports nutrition is expected to benefit from the growing interest in body building and fitness over the forecast period. Value sales are predicted to increase at a CAGR of 2% from 2011 to 2016. Manufacturers are expected to focus on less specialised areas and will offer products for non-professionals who are more general consumers. Women are likely to be the key target group of innovations, as they are more open to healthy lifestyles and usually decide about purchases for the family.

CATEGORY DATA

  • Table 82 Sales of Sports Nutrition: Value 2006-2011
  • Table 83 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 84 Sports Nutrition Company Shares 2007-2011
  • Table 85 Sports Nutrition Brand Shares 2008-2011
  • Table 86 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 87 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Hungary - Category Analysis

HEADLINES

TRENDS

  • Vitamins and dietary supplements continued to benefit from strengthening self-medication and health-promotion trends in Hungary in 2011. Although most Hungarians still faced the lingering negative effects of the economic downturn, they were willing to spend on their health. Manufacturers were also active in terms of product development and advertising, which supported positive growth. Thus, retail value sales increased in 2011.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Béres Gyógyszergyár Zrt led sales in 2011 accounting for 18% of retail value sales due to the traditional popularity and respect of the Béres brand, the wide assortment of products and frequent advertising. Béres brand was represented in many categories and was especially successful in minerals, where Béres Csepp maintained its leading position. Sanofi-Aventis Zrt was second in ranking, accounting for 8% of value sales with Magne B6, the second best-selling mineral dietary supplement and Normaflore, leading probiotic supplement. Teva Magyarország Zrt recorded a 7% retail value share in vitamins and dietary supplements due to such popular products as Eurovit, Bilobil, Saballo or Peponen. Teva Magyarország Zrt has recently increased its research in dietary supplements and has launched numerous new products over the last few years of the review period.

PROSPECTS

  • Vitamins and dietary supplements is expected to develop steadily over the forecast period. Due to strengthening self-medication and health-promotion trends, most Hungarians will consume vitamins and dietary supplements in order to avoid illness. Sales will also be boosted by improving economic circumstances. Manufacturers are expected to launch new products from year to year to benefit from growing consumer interest and they will likely invest more in advertising to gain the most from these new products. Thus, value sales of vitamins and dietary supplements are predicted to increase at a constant CAGR of 2% from 2011 to 2016.

CATEGORY DATA

  • Table 88 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 89 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 90 Dietary Supplements by Positioning 2006-2011
  • Table 91 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 92 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 93 Vitamins Brand Shares by Value 2008-2011
  • Table 94 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 95 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 96 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Hungary - Category Analysis

HEADLINES

TRENDS

  • Being overweight remained a serious health problem for many people in Hungary in 2011. According to Eurostat’s recent survey 21.4% of men and 18.4% of women are overweight in the country. As obesity is the cause of many serious health problems and is considered socially frowned upon, overweight people continue to try to lose weight through different means. Nevertheless, the negative economic effects of the global economic downturn set back demand in 2011 for weight management products as people saved money for more essential items. As a result of this, current value sales of weight management stagnated in 2011.

COMPETITIVE LANDSCAPE

  • Pharma Nord Kft led sales in 2011 holding a sales value share of 8% thanks to its strong position in the biggest subcategory, weight loss supplements. Pharma Nord markets a wide range of popular products like Bio CLA, Bio CLA+T, Bio Slim and Bio Krom. SCB Trade Kft was the second best performing market player due to the continuous success of Metabol. This brand is still the most popular weight loss supplement in Hungary, although it lost significant sales in the previous years and its manufacturer had to pay penalties for misleading advertisements. SCB Trade bought up the Metabol brand in 2010 and preserved its leading position in weight loss supplements. GlaxoSmithKline was third in ranking, accounting for 7% of value sales due to the success of its OTC obesity brand, Alli, which is the only brand present in its category.

PROSPECTS

  • Value sales of weight management are predicted to increase at a CAGR of 1% over the forecast period. As obesity is a serious problem for many Hungarians, losing weight will remain an important aim for thousands of people. Therefore, more and more Hungarians are expected to spend on slimming products over the forecast period, however, growth is predicted be limited due to economic circumstances.

CATEGORY DATA

  • Table 97 Sales of Weight Management: Value 2006-2011
  • Table 98 Sales of Weight Management: % Value Growth 2006-2011
  • Table 99 Weight Management Company Shares 2007-2011
  • Table 100 Weight Management Brand Shares 2008-2011
  • Table 101 Forecast Sales of Weight Management: Value 2011-2016
  • Table 102 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Hungary - Category Analysis

HEADLINES

TRENDS

  • 2011 was mainly uneventful in wound care. Manufacturers did not invest remarkably in product development; amid the current economic circumstances Hungarians were not interested in more sophisticated products. Moreover, many people turned to cheaper private label or low quality brands, as they thought that these brands’ quality was not much lower than that of the leading brands.

COMPETITIVE LANDSCAPE

  • Beiersdorf Kft led sales in 2011 with a value share of 27% due to the success of its Leukoplast and Hansaplast brands. Hansaplast was the second best-selling brand in sticking plasters, while in gauze, tape and other wound care, both brands held strong positions. Hartmann-Rico Hungária Kft was second in ranking holding a 16% value share thanks to its leading position in gauze, tape and other wound care. Nagév Kötszer Kft held the third position with nearly 16% of retail value sales, as its Pharmico brand was present both in sticking plasters and in gauze, tape and other wound care.

PROSPECTS

  • Value sales of wound care are predicted to slightly decrease in constant terms over the forecast period. Wound care has reached maturity and in the current economic circumstances manufacturers do not invest in product development, they rather focus on maintaining their position. Price-sensitive consumers will likely opt for cheaper brands while brand-loyal customers will search for sales promotions to save money. Nevertheless, increasing unit prices are predicted to balance constant sales decrease from year to year.

CATEGORY DATA

  • Table 103 Sales of Wound Care by Category: Value 2006-2011
  • Table 104 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 105 Wound Care Company Shares by Value 2007-2011
  • Table 106 Wound Care Brand Shares by Value 2008-2011
  • Table 107 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 108 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Aloe
            • Green Tea Extract
            • Pumpkin Seed
            • Saw Palmetto
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Lecithin
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!